Exchange: NYSE·Updated 04:10 PM EDT
Latest Earnings Results: Q3 '26

Reported: Aug 03

Estimated EPS

-$0.35

Reported EPS

---

Surprise

---

Estimated Rev

$72.7M

Reported Rev

$76.38M

Surprise

+5.07%

$MED Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.28 down -221.74% YoY • Reported revenue of $76.38M down -27.64% YoY • Medifast expects third quarter 2026 revenue of $60 million to $80 million, with a loss per share of $0.15 to $0.65, and full year 2026 revenue of $270 million to $300 million.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.35
--
--
N/A
Q2 '26
-$0.65
--
--
N/A
Q1 '26
-$0.52
-$0.19
63.46%
BEAT
Q4 '25
-$0.82
-$0.55
32.93%
BEAT
Q3 '25
-$0.36
-$0.21
41.67%
BEAT

Advertisement|Remove ads.